SPIRONOLACTONE IN FIRST-LINE ANTIHYPERTENSIVE THERAPY: EFFECT ON VASCULAR REMODELING
Introduction. Previously, clinical studies have proven a pronounced antihypertensive effect of spironolactone in patients with true resistant hypertension. The effectiveness of spironolactone as part of first-line therapy, as well as the effect on vascular wall remodeling, has not been studied.Targe...
Main Author: | Anna Mikhailovna Torunova |
---|---|
Format: | Article |
Language: | English |
Published: |
Ministry of Health of the Russian Federation, Irkutsk State Medical University
2023-09-01
|
Series: | Байкальский медицинский журнал |
Subjects: | |
Online Access: | https://www.bmjour.ru/jour/article/view/156 |
Similar Items
-
Design and progress of a factorial trial testing the effect of spironolactone and inorganic nitrate on arterial function in people at risk of or with type 2 diabetes
by: Charlotte E. Mills, et al.
Published: (2015-11-01) -
Drug Correction of Vascular Remodeling in Patients with Hypertension: Results of 52-Week Prospective Study ARTERIA-AG
by: O. V. Fedorishina, et al.
Published: (2020-05-01) -
Effect of spironolactone use in pulmonary arterial hypertension – analysis from pivotal trial databases
by: Zeenat Safdar, et al.
Published: (2021-10-01) -
Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy
by: Revathy Carnagarin, et al.
Published: (2021-07-01) -
Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive rat
by: Catherine J. Leader, et al.
Published: (2020-05-01)